InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,303.27
(
0.12%
)
US TECH 100
18,062.00
(
-0.10%
)
Dow Jones
40,003.59
(
0.34%
)
Brent Oil
83.76
(
0.00%
)
Bitcoin
67,024.20
(
-0.08%
)
Post# of 251852
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

ronpopeil

Send PM Follow Ignore
Followers 122
Posts 8884
Boards Moderated 0
Alias Born 10/05/2004

ronpopeil

Re: None

Thursday, 07/29/2021 8:16:28 PM

Thursday, July 29, 2021 8:16:28 PM

Post# of 251852
BeiGene Announces Positive Topline Results from Phase 3 SEQUOIA Trial Comparing BRUKINSA® (Zanubrutinib) to Bendamustine Plus Rituximab in Patients with Treatment-Naïve Chronic Lymphocytic Leukemia


https://www.businesswire.com/news/home/20210729006225/en/BeiGene-Announces-Positive-Topline-Results-from-Phase-3-SEQUOIA-Trial-Comparing-BRUKINSA%C2%AE-Zanubrutinib-to-Bendamustine-Plus-Rituximab-in-Patients-with-Treatment-Na%C3%AFve-Chronic-Lymphocytic-Leukemia

"Don't worry about the world coming to an end today. It's already tomorrow in Australia"

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up